The state of UK drug discovery: the pharmaphorum podcast

from pharmaphorum Podcast · host pharmaphorum

The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the pharmaphorum podcast. On it I spoke with Chris Molloy, who’s CEO at the UK’s Medicines Discovery Catapult, about the Catapult’s State of the Discovery Nation publication, a joint report with the UK’s biotech trade body the BioIndustry Association.

Episode metadata supplied by the publisher feed · Published Jul 19, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

The state of UK drug discovery: the pharmaphorum podcast

0:00 32:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 32 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on July 19, 2019.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!